Report Search Results	As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 38) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 9-Feb-10 New Constructs, LLC N/A WPI: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10     View Abstract 8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) 144 $169     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169     View Abstract 6-Feb-10 Reuters Investment Profile N/A Waterfront Philippines Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20     View Abstract 6-Feb-10 Reuters Investment Profile N/A Watson Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: AGN , FRX , NVO , SHPGY , WPI -- DRUGS 3 $4     View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of WATSON PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: WATSON PHARMACEU -- WPI 1 $4     View Abstract Next 20

Brokerage Reports (Showing 1 to 8 of 8) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 1-Feb-10 Collins Stewart LLC Louise Chen Emergency Contraceptive Deal Expands WPI's WHC Franchise 2 $10     View Abstract 21-Jan-10 Collins Stewart LLC Louise Chen Analyst Day Improves Visibility For Long-Term Growth 13 $50     View Abstract 20-Jan-10 Collins Stewart LLC Louise Chen February 2010 Catalyst Calendar 25 $75     View Abstract 19-Jan-10 Collins Stewart LLC Louise Chen ANDA Filing Negative for ENDP and Positive for WPI 3 $10     View Abstract 13-Jan-10 Collins Stewart LLC Louise Chen 2009 Earnings Upside and 2010 Sales Guidance Are Good for WPI 2 $10     View Abstract 13-Jan-10 Thomson StreetEvents N/A WPI - Event Transcript of Watson Pharmaceuticals, Inc. conference call, Jan. 13, 2010 / 12:00pm ET 8 $75     View Abstract 31-Dec-09 First Global Kavita Thomas, Devina Mehra First Global reiterates Outperform on TEVA 14 $50     View Abstract 20-Mar-09 Collins Stewart LLC Louise Chen Key Takeaways From Meeting With Strides Arcolab 3 $12     View Abstract

Independent Reports (Showing 1 to 10 of 30) Release Date  Contributor Author Title Pages Price More Info 9-Feb-10 New Constructs, LLC N/A WPI: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract 8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) 144 $169 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract 6-Feb-10 Reuters Investment Profile N/A Waterfront Philippines Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract 6-Feb-10 Reuters Investment Profile N/A Watson Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: AGN , FRX , NVO , SHPGY , WPI -- DRUGS 3 $4 View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of WATSON PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: WATSON PHARMACEU -- WPI 1 $4 View Abstract Next 20